These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37647563)

  • 1. Evaluation of (2S,4S)-4-[
    Huang Y; Liu Y; Li C; Li Z; Chen H; Zhang L; Liang Y; Wu Z
    Mol Pharm; 2023 Oct; 20(10):5195-5205. PubMed ID: 37647563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, and Biological Evaluation of a Novel [
    Huang Y; Li C; Li Z; Xie Y; Chen H; Li S; Liang Y; Wu Z
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of Precursor Synthesis Conditions of (2S,4S)4-[
    Huang Y; Zhang L; Wang M; Li C; Zheng W; Chen H; Liang Y; Wu Z
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 36015094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[
    Pollard AC; Paolillo V; Radaram B; Qureshy S; Li L; Maity T; Wang L; Uddin MN; Wood CG; Karam JA; Pagel MD; Piwnica-Worms D; Millward SW; Fowlkes NW; Norton W; Engel BJ; Pisaneschi F; Zacharias NM
    Mol Imaging Biol; 2022 Dec; 24(6):959-972. PubMed ID: 35732988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic Modeling of
    Viswanath V; Zhou R; Lee H; Li S; Cragin A; Doot RK; Mankoff DA; Pantel AR
    J Nucl Med; 2021 Aug; 62(8):1154-1162. PubMed ID: 33277391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET Imaging of
    Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z
    Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (2S, 4R)-4-[
    Miner MW; Liljenbäck H; Virta J; Merisaari J; Oikonen V; Westermarck J; Li XG; Roivainen A
    Mol Imaging Biol; 2020 Aug; 22(4):969-978. PubMed ID: 31993927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and preliminary evaluation of a novel glutamine derivative: (2S,4S)4-[
    Huang Y; Liu S; Wu R; Zhang L; Zhang Y; Hong H; Zhang A; Xiao H; Liu Y; Wu Z; Zhu L; Kung HF
    Bioorg Med Chem Lett; 2019 May; 29(9):1047-1050. PubMed ID: 30871772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.
    Wu Z; Zha Z; Li G; Lieberman BP; Choi SR; Ploessl K; Kung HF
    Mol Pharm; 2014 Nov; 11(11):3852-66. PubMed ID: 25095908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
    Lieberman BP; Ploessl K; Wang L; Qu W; Zha Z; Wise DR; Chodosh LA; Belka G; Thompson CB; Kung HF
    J Nucl Med; 2011 Dec; 52(12):1947-55. PubMed ID: 22095958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
    Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
    Front Immunol; 2022; 13():821423. PubMed ID: 35145523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorination at the 4 position alters the substrate behavior of L-glutamine and L-glutamate: Implications for positron emission tomography of neoplasias.
    Jeitner TM; Kristoferson E; Azcona JA; Pinto JT; Stalnecker C; Erickson JW; Kung HF; Li J; Ploessl K; Cooper AJL
    J Fluor Chem; 2016 Dec; 192(A):58-67. PubMed ID: 28546645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Evaluation of [
    Zheng W; Huang Y; Xie Y; Yang T; Cheng X; Chen H; Li C; Jiang Z; Yu Z; Li Z; Zhang L; Yuan L; Liu Y; Liang Y; Wu Z
    Mol Pharm; 2024 May; 21(5):2606-2621. PubMed ID: 38606716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS Mutation Detection with (2
    Liu S; Liu F; Hou X; Zhang Q; Ren Y; Zhu H; Yang Z; Xu X
    Mol Pharm; 2024 Apr; 21(4):2034-2042. PubMed ID: 38456403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[
    Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H
    Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Imaging of Glutamine in Cancer.
    Zhu L; Ploessl K; Zhou R; Mankoff D; Kung HF
    J Nucl Med; 2017 Apr; 58(4):533-537. PubMed ID: 28232608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of
    Dunphy MPS; Harding JJ; Venneti S; Zhang H; Burnazi EM; Bromberg J; Omuro AM; Hsieh JJ; Mellinghoff IK; Staton K; Pressl C; Beattie BJ; Zanzonico PB; Gerecitano JF; Kelsen DP; Weber W; Lyashchenko SK; Kung HF; Lewis JS
    Radiology; 2018 May; 287(2):667-675. PubMed ID: 29388903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side Chain Optimization Remarkably Enhances the in Vivo Stability of
    Chen J; Li C; Hong H; Liu H; Wang C; Xu M; Han Y; Liu Z
    Mol Pharm; 2019 Dec; 16(12):5035-5041. PubMed ID: 31670970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of [
    Wu R; Liu S; Liu Y; Sun Y; Cheng X; Huang Y; Yang Z; Wu Z
    Eur J Med Chem; 2019 Dec; 183():111730. PubMed ID: 31563014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.